150 related articles for article (PubMed ID: 31294795)
1. Hydroxylated Long-Chain Acylcarnitines are Biomarkers of Mitochondrial Myopathy.
Vissing CR; Dunø M; Wibrand F; Christensen M; Vissing J
J Clin Endocrinol Metab; 2019 Dec; 104(12):5968-5976. PubMed ID: 31294795
[TBL] [Abstract][Full Text] [Related]
2. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
[TBL] [Abstract][Full Text] [Related]
3. Production and release of acylcarnitines by primary myotubes reflect the differences in fasting fat oxidation of the donors.
Wolf M; Chen S; Zhao X; Scheler M; Irmler M; Staiger H; Beckers J; de Angelis MH; Fritsche A; Häring HU; Schleicher ED; Xu G; Lehmann R; Weigert C
J Clin Endocrinol Metab; 2013 Jun; 98(6):E1137-42. PubMed ID: 23633211
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
[TBL] [Abstract][Full Text] [Related]
5. Effect of supplementation with L-carnitine at a small dose on acylcarnitine profiles in serum and urine and the renal handling of acylcarnitines in a patient with multiple acyl-coenzyme A dehydrogenation defect.
Yoshino M; Tokunaga Y; Watanabe Y; Yoshida I; Sakaguchi M; Hata I; Shigematsu Y; Kimura M; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(1):73-82. PubMed ID: 12828999
[TBL] [Abstract][Full Text] [Related]
6. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy.
Westermann CM; Dorland L; Votion DM; de Sain-van der Velden MG; Wijnberg ID; Wanders RJ; Spliet WG; Testerink N; Berger R; Ruiter JP; van der Kolk JH
Neuromuscul Disord; 2008 May; 18(5):355-64. PubMed ID: 18406615
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine.
Chalmers RA; Roe CR; Stacey TE; Hoppel CL
Pediatr Res; 1984 Dec; 18(12):1325-8. PubMed ID: 6441143
[TBL] [Abstract][Full Text] [Related]
8. Carnitine palmitoyltransferase 2: New insights on the substrate specificity and implications for acylcarnitine profiling.
Violante S; Ijlst L; van Lenthe H; de Almeida IT; Wanders RJ; Ventura FV
Biochim Biophys Acta; 2010 Sep; 1802(9):728-32. PubMed ID: 20538056
[TBL] [Abstract][Full Text] [Related]
9. Renal handling of carnitine in secondary carnitine deficiency disorders.
Stanley CA; Berry GT; Bennett MJ; Willi SM; Treem WR; Hale DE
Pediatr Res; 1993 Jul; 34(1):89-97. PubMed ID: 8356025
[TBL] [Abstract][Full Text] [Related]
10. An unusually high frequency of SCAD deficiency caused by two pathogenic variants in the ACADS gene and its relationship to the ethnic structure in Slovakia.
Lisyová J; Chandoga J; Jungová P; Repiský M; Knapková M; Machková M; Dluholucký S; Behúlová D; Šaligová J; Potočňáková Ľ; Lysinová M; Böhmer D
BMC Med Genet; 2018 Apr; 19(1):64. PubMed ID: 29678161
[TBL] [Abstract][Full Text] [Related]
11. Short-chain acyl-CoA dehydrogenase deficiency: a cause of ophthalmoplegia and multicore myopathy.
Tein I; Haslam RH; Rhead WJ; Bennett MJ; Becker LE; Vockley J
Neurology; 1999 Jan; 52(2):366-72. PubMed ID: 9932958
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
[TBL] [Abstract][Full Text] [Related]
13. Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders.
Shen JJ; Matern D; Millington DS; Hillman S; Feezor MD; Bennett MJ; Qumsiyeh M; Kahler SG; Chen YT; Van Hove JL
J Inherit Metab Dis; 2000 Feb; 23(1):27-44. PubMed ID: 10682306
[TBL] [Abstract][Full Text] [Related]
14. Impact of short- and medium-chain organic acids, acylcarnitines, and acyl-CoAs on mitochondrial energy metabolism.
Sauer SW; Okun JG; Hoffmann GF; Koelker S; Morath MA
Biochim Biophys Acta; 2008 Oct; 1777(10):1276-82. PubMed ID: 18582432
[TBL] [Abstract][Full Text] [Related]
15. The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency.
Costa CG; Dorland L; de Almeida IT; Jakobs C; Duran M; Poll-The BT
J Inherit Metab Dis; 1998 Jun; 21(4):391-9. PubMed ID: 9700596
[TBL] [Abstract][Full Text] [Related]
16. Correcting false positive medium-chain acyl-CoA dehydrogenase deficiency results from newborn screening; synthesis, purification, and standardization of branched-chain C8 acylcarnitines for use in their selective and accurate absolute quantitation by UHPLC-MS/MS.
Minkler PE; Stoll MSK; Ingalls ST; Hoppel CL
Mol Genet Metab; 2017 Apr; 120(4):363-369. PubMed ID: 28190699
[TBL] [Abstract][Full Text] [Related]
17. Effect of heat stress and bezafibrate on mitochondrial beta-oxidation: comparison between cultured cells from normal and mitochondrial fatty acid oxidation disorder children using in vitro probe acylcarnitine profiling assay.
Li H; Fukuda S; Hasegawa Y; Kobayashi H; Purevsuren J; Mushimoto Y; Yamaguchi S
Brain Dev; 2010 May; 32(5):362-70. PubMed ID: 19589653
[TBL] [Abstract][Full Text] [Related]
18. [Study of plasma acylcarnitines using tandem mass spectrometry. Application to the diagnosis of metabolism hereditary diseases].
Delolme F; Vianey-Saban C; Guffon N; Favre-Bonvin J; Guibaud P; Becchi M; Mathieu M; Divry P
Arch Pediatr; 1997 Sep; 4(9):819-26. PubMed ID: 9345561
[TBL] [Abstract][Full Text] [Related]
19. Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease.
Saiki S; Hatano T; Fujimaki M; Ishikawa KI; Mori A; Oji Y; Okuzumi A; Fukuhara T; Koinuma T; Imamichi Y; Nagumo M; Furuya N; Nojiri S; Amo T; Yamashiro K; Hattori N
Sci Rep; 2017 Aug; 7(1):7328. PubMed ID: 28779141
[TBL] [Abstract][Full Text] [Related]
20. Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress.
Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Exil V; Duran M; Wijburg FA; Wanders RJ; Strauss AW
Eur J Clin Invest; 2004 Mar; 34(3):191-6. PubMed ID: 15025677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
